Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hawkins Richard J, Chairman & CEO. Officer active across 5 companies, notably Savara Inc. In total, 21 reports have been recorded. Split: 7 buys · 0 sell. Total volume traded: €134k. History available since 13 December 2021. The latest transaction was filed on 9 December 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hawkins Richard J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
728 shares@ US$0.550.4% of flowCommon StockSEC:0001209191-21-069582:0
21 of 21 declarations
About Hawkins Richard J
Président-Directeur Général, Hawkins Richard J has filed 21 disclosures. In the recent filings tracked, they cover the period from 2021-12-14 to 2025-12-11, with EUR 133539 of purchases and EUR 0 of sales. They are also Chief Executive Officer of Lumos Pharma, INC., as well as Director of Savara Inc and Plus Therapeutics, INC.